MINESH PATEL: Open Payments
NPI 1033409073 · DOBBS FERRY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 91 payments from 11 companies in 2025. Trend: 2023 $1,975 · 2024 $3,016 · 2025 $1,962
Food & beverage: $1,962
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $507 |
| Corium, LLC | 22 | $421 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $318 |
| Otsuka America Pharmaceutical, Inc. | 8 | $190 |
| Neurocrine BioSciences, Inc. | 8 | $168 |
| Collegium Pharmaceutical, Inc. | 4 | $91 |
| Tris Pharma Inc | 4 | $82 |
| Abbott Laboratories | 3 | $71 |
| Vertical Pharmaceuticals, LLC | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
Products named: VRAYLAR, Azstarys, CAPLYTA, REXULTI, INGREZZA, Jornay PM, PROCLAIM, Dyanavel XR.
Industry payments across NY — which companies pay providers there.
